Cannabis Is Also Beneficial For Treating Lupus
Although well known, marijuana has a number of properties that make it especially suitable for medicinal use. In this case it has been discovered that this substance is a good remedy against lupus, a chronic disease that causes the patient’s autoimmune system to attack the body’s own tissues and healthy organs. We then explain more fully this disease, what its symptoms are and the benefits of cannabis in its treatment.
Cannabis is also beneficial for treating lupus
The immune system is designed to fight foreign substances and foreign to the body when, for example, we catch a cold. If this process fails, and it is the system itself that attacks the body’s healthy cells and tissues, a disease commonly known as lupus occurs .
It is a chronic disease affecting about five million people in the world , of which 90% are women. Lupus is more common in African-American, Hispanic, Asian, and Native American women than among white-skinned women. There are several types, although the common is SLE(Systemic Lupus Erythematosus). As in all forms of the variety, the symptoms in each patient may differ drastically from those of others. However, the disease mainly affects joints, skin, kidneys, heart, blood vessels and the brain.
In the most serious complications, lupus causes a high blood pressure in the lungs, which makes breathing difficult. In addition, it causes inflammation in the kidneys and brain , undermining the ability of the first to filter the blood and causing a whole series of neurological problems, including the possibility of stroke. The disease also affects the arteries and increases the risk of having a heart attack.
The traditional treatment of lupus revolves around the management of outbreaks once they have been produced under drugs that suppress the immune system. With this function, hydroxychloroquine (HCQ) , a drug that has proved to be toxic to the eyes , has been used for decades .
More recently, the FDA, which regulates drugs in the United States, has approved the use of belimumab for the treatment of SLE. Early studies indicate that this substance is “marginally effective.” If we consider its price, about $ 35,000 a year (30,900 euros) , it is not surprising that patients claim a cheaper and more effective drug.